LyocartE MTB 检测结核的多中心诊断准确性研究
在中国 3 个中心连续纳入 689 例疑似结核患者,同时采集痰和舌拭子,用 LyocartE 检测并与 Xpert Ultra、涂片和培养比较。以 MRS 为标准,痰 LyocartE 灵敏度 95.2%、特异度 98.6%;舌拭子对痰 Xpert Ultra 灵敏度 87.4%、特异度 99.7%。LyocartE 与 Xpert Ultra 的 Ct 值呈强相关。
要点
- 痰 LyocartE 对 MRS 灵敏度 95.2%、特异度 98.6%,接近 Xpert Ultra。
- 舌拭子 LyocartE 对 MRS 灵敏度 84.1%、特异度 99.7%,优于对痰 Xpert Ultra 的灵敏度 87.4%。
- 舌拭子等非痰标本可用于近点检测结核,但无症状和少菌人群尚待验证。
核心结论
- 近点检测 LyocartE 可从痰和舌拭子中快速、准确检出结核,痰标本性能与 Xpert Ultra 相当,舌拭子分析灵敏度更优。
研究设计与样本
- 多中心前瞻性诊断准确性研究,在中国 3 个中心连续纳入 689 例疑似结核患者,采集痰和舌拭子,与 Xpert Ultra、涂片和培养比较,对照 Xpert Ultra 结果和复合微生物参考标准(MRS)评估。
主要发现
- 痰 LyocartE 对 MRS 灵敏度 95.2%、特异度 98.6%。
- 舌拭子 LyocartE 对痰 Xpert Ultra 灵敏度 87.4%、特异度 99.7%。
- 舌拭子 LyocartE 对 MRS 灵敏度 84.1%、特异度 99.7%。
- LyocartE 与 Xpert Ultra Ct 值强相关:痰 r=0.7476,P<.0001;舌拭子 r=0.5607,P<.0001。
- LyocartE 诊断准确性在不同标本类型、临床症状和合并症间保持稳健。
关键数值与推荐
- 痰 LyocartE 对 MRS:灵敏度 95.2%,特异度 98.6%。
- 舌拭子 LyocartE 对痰 Xpert Ultra:灵敏度 87.4%,特异度 99.7%。
- 舌拭子 LyocartE 对 MRS:灵敏度 84.1%,特异度 99.7%。
- LyocartE 与 Xpert Ultra Ct 值相关:痰 r=0.7476(P<.0001),舌拭子 r=0.5607(P<.0001)。
临床怎么用
- LyocartE 可在近点用痰或舌拭子快速检测结核,舌拭子适合留痰困难者,但其无症状和少菌人群表现需进一步评估。
局限性
- 需在无症状和少菌(paucibacillary)人群中进一步评估以确认结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tuberculosis (TB) continues to pose a major threat to global public health. The development of rapid near point-of-care diagnostics utilizing non-sputum specimens is critical for advancing TB control efforts. METHODS: In this multicenter prospective diagnostic accuracy study, 689 consecutive individuals with presumptive TB were enrolled from 3 sites in China. Sputum and tongue swab specimens were collected from all participants for index testing with the LyocartE assay and comparator testing with Xpert Ultra, smear microscopy, and culture. The diagnostic performance of LyocartE for active TB was evaluated against 2 pre-defined reference standards: Xpert Ultra results and the composite microbiological reference (MRS) standard. RESULTS: Among the 689 participants analyzed, LyocartE on sputum demonstrated a sensitivity of 95.2% and specificity of 98.6% against the MRS. For tongue swab specimens compared to sputum Xpert Ultra results, LyocartE sensitivity was 87.4% with a specificity of 99.7%. When evaluated against MRS for tongue swabs, sensitivity was 84.1% and specificity was 99.7%. The diagnostic accuracy of LyocartE remained robust across specimen types, clinical symptoms, and comorbidities. Strong correlation was observed between LyocartE and Xpert Ultra cycle threshold (Ct) values (sputum: r = 0.7476, P < .0001; tongue swab: r = 0.5607, P < .0001). CONCLUSIONS: The near point-of-care LyocartE assay offers rapid and accurate TB detection from both sputum and tongue swab specimens. Its performance is comparable to Xpert Ultra on sputum and demonstrates improved sensitivity for tongue swab analysis. Further evaluation in asymptomatic and paucibacillary populations is urgently required to confirm these findings.
引用
- Ma Z, Yu X, Yu Y, et al. Near-point-of-care Diagnosis of Tuberculosis With LyocartE MTB Assay: a Multicenter Diagnostic Accuracy Study. Clin Infect Dis. 2026. PMID: 42212698. doi:10.1093/cid/ciag342
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。